LVAD Survival Better When Combined with ICD
|
By HospiMedica International staff writers Posted on 19 Jul 2016 |
|
Image: According to a new study, patient survival with a left ventricular assist device (LVAD) is better when an implantable cardioverter defibrillator (ICD) is also present (Photo courtesy of BCM).
Researchers at the Minneapolis Veterans Affairs (VA) Health Care System (MN, USA) conducted a systematic review and meta-analysis of studies published in PubMed and OVID databases from January 2000 through October 2015 in order to evaluate the impact of ICDs on mortality in patients with LVADs. In all, six relevant studies were identified, which included 937 patients (mean age 53 years, 80% male). A continuous-flow LVAD was present in 39% of the patients, and an ICD was present in 38%.
The results showed that among LVAD patients, all-cause mortality rates were 16% with an ICD, versus 32% without one, over a mean follow-up period of 7 months. Patients with newer, continuous flow LVADs showed a similar, but non-significant trend for better survival with an ICD (14% versus 25%, respectively). The authors acknowledged that they failed to totally exclude patients with biventricular assist devices (17%) and right ventricular assist devices (4%). The study was published in the July 2016 issue of JACC: Heart Failure.
“The evidence supporting ICD use in patients with LVADs is limited to a few, relatively small studies. Current practice guidelines supporting ICD use in LVAD patients are therefore predominantly based on expert consensus and observational studies,” wrote lead author Kairav Vakil, MD, and colleagues, adding that, “this cohort was enriched with patients that received an LVAD as bridge-to-transplantation. As such, these results cannot be generalized to patients receiving destination therapy LVADs, who are known to be relatively sicker than those awaiting transplantation.”
An LVAD is intended to complement a weakened heart by providing circulatory support. Surgically implanted in proximity to the heart, one end is attached to the left ventricle, while the other is attached to the aorta. Blood flows from the ventricles into the pump and is then ejected out of the device and into the aorta. Although the mechanism of survival benefit from ICDs in LVAD patients remains unclear, a possible explanation is that it may contribute to a reduction in harmful effects of ventricular arrhythmias on right ventricular function, thereby leading to reduction of heart failure deaths.
Related Links:
Minneapolis Veterans Affairs
The results showed that among LVAD patients, all-cause mortality rates were 16% with an ICD, versus 32% without one, over a mean follow-up period of 7 months. Patients with newer, continuous flow LVADs showed a similar, but non-significant trend for better survival with an ICD (14% versus 25%, respectively). The authors acknowledged that they failed to totally exclude patients with biventricular assist devices (17%) and right ventricular assist devices (4%). The study was published in the July 2016 issue of JACC: Heart Failure.
“The evidence supporting ICD use in patients with LVADs is limited to a few, relatively small studies. Current practice guidelines supporting ICD use in LVAD patients are therefore predominantly based on expert consensus and observational studies,” wrote lead author Kairav Vakil, MD, and colleagues, adding that, “this cohort was enriched with patients that received an LVAD as bridge-to-transplantation. As such, these results cannot be generalized to patients receiving destination therapy LVADs, who are known to be relatively sicker than those awaiting transplantation.”
An LVAD is intended to complement a weakened heart by providing circulatory support. Surgically implanted in proximity to the heart, one end is attached to the left ventricle, while the other is attached to the aorta. Blood flows from the ventricles into the pump and is then ejected out of the device and into the aorta. Although the mechanism of survival benefit from ICDs in LVAD patients remains unclear, a possible explanation is that it may contribute to a reduction in harmful effects of ventricular arrhythmias on right ventricular function, thereby leading to reduction of heart failure deaths.
Related Links:
Minneapolis Veterans Affairs
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Pediatric Mask
Respire SOFT
Patient Monitoring System
AlarmSense
Latest Critical Care News
- Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible
- New Sensor Could Bring Contactless Vital Sign Monitoring to Hospital Bedsides
- Diamond-Based Magnetometers Could Enable New Approaches to Heart Monitoring
- Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries
- Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease
- FDA Clears Multi-Device ECG Analysis Software for Extended Monitoring
- Multimodal AI Improves Treatment Response Prediction in Lung Cancer
- New Approach Helps Identify Materials for More Reliable Wearable Electronics
- Scotland Adopts Respiratory Infection Control Guidance Informed by Aerosol Research
- Hospital Safety Program Linked to 65% Reduction in MRSA Bloodstream Infections
- Wearable Microneedle Device Aims to Enable Remotely Managed Pain Relief
- Octopus-Inspired Patch Improves Adhesion for Transdermal Drug Delivery
- Multimodal AI System Tracks Early Warning Signs of Mental Health Crisis
- Self-Folding Paper Sensor Conforms to Body Without Straps or Adhesives
- Patch-Based Therapy Promotes Myelin Repair in Multiple Sclerosis
- Rapid EHR Surveillance Helps Protect High-Risk Patients During Heat Waves
Channels
Artificial Intelligence
view channel
AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment
Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more
AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment
Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U.S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify... Read more
Surgical Techniques
view channel
Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses
Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more
FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis
Coronary in-stent restenosis (ISR) accounts for about 10% of the nearly one million percutaneous coronary interventions performed annually in the United States. Treating recurrent narrowing without another... Read more
Patient Care
view channel
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Medical Imaging
view channel
AI Tool Integrates MRI and Ultrasound to Detect Endometriosis
Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, heavy bleeding, and infertility. Diagnosis often depends on surgical visualization,... Read more
New MRI Index Reveals How Brain Blood Flow Supports Cellular Energy Needs
The human brain has minimal energy reserves and relies on tightly regulated blood flow to meet its high metabolic demands. However, clinicians have lacked noninvasive tools to assess how cortical perfusion... Read more
Health IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more
